for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Financials

BRIEF-Jazz Pharmaceuticals says majority of Celator's outstanding shares has been validly tendered

July 12 (Reuters) - Jazz Pharmaceuticals Plc

* Tender offer is being effected by Jazz Pharmaceuticals’ indirect wholly-owned subsidiary, Plex Merger Sub

* Condition to tender offer that majority of Celator’s outstanding shares be validly tendered has now been satisfied

* Announced results of its tender offer to purchase all of outstanding shares of common stock of Celator Pharmaceuticals Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up